Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

Bristol-Myers Squibb - revenue share of key products 2006-2020

Bristol-Myers Squibb's revenue from key products as a percentage of total revenue from 2006 to 2020

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2021

Region

Worldwide

Survey time period

2006 to 2020

Supplementary notes

This statistic was assembled from several of BMS' financial reports.
* Calculated from data available on page 3 of the 2015 Form 10-K and page 7 of the 2016 Form 10-K.
** Key products = 6 prioritized products.
*** Key products = 10 prioritized products. Revenues in 2019 were already impacted by the acquisition of Celgene (Revlimid, e.g.). br>**** Key products = 13 prioritized products.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.